Fig. 4: Evaluation of tertiary lymphoid structure (TLS) density and maturity in resected specimens from prior surgery, in association with response to anti-PD-1 antibody and survival in a different cohort of 34 patients with recurrent oesophageal cancer. | British Journal of Cancer

Fig. 4: Evaluation of tertiary lymphoid structure (TLS) density and maturity in resected specimens from prior surgery, in association with response to anti-PD-1 antibody and survival in a different cohort of 34 patients with recurrent oesophageal cancer.

From: Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors

Fig. 4

a Scheme of treatment course and CT/PET-CT images of target lesions (white arrowheads), and H&E images of TLS (yellow arrowheads) in whole tumour sections from a representative responder (left) and non-responder (right) to anti-PD-1 antibody. b TLS density according to pT in recurrent oesophageal cancer patients treated with anti-PD-1 antibody. c, d TLS density according to two (c) and four (d) categories of response to anti-PD-1 antibody. e Comparison of TLS maturity according to response to anti-PD-1 antibody. Red lines and the numbers next to them show median. f Kaplan–Meier survival curve of PFS according to TLS density in resected specimens from prior surgery. Comparisons were made by Mann–Whitney U test for continuous variables, and a log-rank test for survival analysis.

Back to article page